VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $317 | -67.2% | 149,690 | -52.1% | 0.00% | -50.0% |
Q2 2023 | $967 | -43.0% | 312,652 | -0.8% | 0.00% | -50.0% |
Q1 2023 | $1,696 | -16.9% | 315,209 | +2.7% | 0.00% | -20.0% |
Q4 2022 | $2,040 | -99.8% | 306,811 | +1.5% | 0.01% | +66.7% |
Q3 2022 | $1,204,000 | -15.6% | 302,412 | +5.4% | 0.00% | -25.0% |
Q2 2022 | $1,426,000 | -22.8% | 286,852 | -6.2% | 0.00% | 0.0% |
Q1 2022 | $1,847,000 | -48.1% | 305,825 | -0.1% | 0.00% | -42.9% |
Q4 2021 | $3,558,000 | -25.3% | 306,143 | +0.8% | 0.01% | -30.0% |
Q3 2021 | $4,764,000 | -8.3% | 303,798 | +9.1% | 0.01% | -9.1% |
Q2 2021 | $5,194,000 | -56.6% | 278,480 | +0.3% | 0.01% | -57.7% |
Q1 2021 | $11,972,000 | – | 277,777 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |